← FDA DRUG APPROVALS

FDA ANDA · ANDA060076

STREPTOMYCIN SULFATE

Sponsor: PFIZER

APPLICATION
ANDA060076
TYPE
ANDA
ORIGINAL APPROVAL
1946-02-18
LATEST ACTION
1989-08-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

STREPTOMYCIN SULFATEDiscontinued
STREPTOMYCIN SULFATE EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
STREPTOMYCIN SULFATEDiscontinued
STREPTOMYCIN SULFATE EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

1989-08-03Manufacturing (CMC) · Supplement 4AP
1946-02-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →